Which risk increases when a pharmaceutical protein's glycosylation pattern is unnaturally altered during molecular manufacturing within engineered cells?

💡 Explanation

When glycosylation is altered, the protein's surface is modified exposing new epitopes because cells recognize altered sugar structures as foreign, triggering immune responses. Therefore enhanced immunogenicity results, rather than aggregation, degradation, or structural changes which require different protein misfolding or enzymatic mechanisms.

• Which outcome occurs when an aluminum semiconductor's doping concentration grows past threshold?
• Which outcome happens when parasitic capacitance forms in integrated circuit pathways?
• Which limitation appears in a Carnot heat engine operating isothermally?
• Which consequence results when bias induces interband tunneling?
• Which outcome arises when a molecule vibrates at a frequency matching its resonant molecular frequency?
• Which risk increases when a jet engine turbine's blades exceed maximum temperature?